Atrioventricular synchrony maintained by a dual-chamber leadless pacemaker in real-world conditions
Open Access
- 19 January 2026
- journal article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (2)
Abstract
Aims: A dual-chamber leadless pacemaker (LP) system relies on a beat-to-beat, wireless, implant-to-implant (i2i™) communication between implanted devices in the right atrium and right ventricle (A-to-V and V-to-A). Atrioventricular (AV) synchrony was evaluated during an ambulatory 24 h period of daily living to determine if its effectiveness can be maintained under real-world conditions. Methods and results: A prospective, single-arm, multicentre clinical study (ClinicalTrials.gov identifier NCT05252702) evaluated the overall safety and performance of the dual-chamber LPs in patients with standard indications for dual-chamber pacing. Following the 3-month visit, eligible patients wore 12-lead Holter monitors for 24 h while resuming the activities of daily living while under clinically driven programmed settings. Leadless pacemaker diagnostic data were interrogated when patients returned to the clinic. An independent Holter core laboratory adjudicated the proportion of synchronous beats (PR intervals within paced and sensed AV delay bounds). Relationships between AV synchrony and i2i communication success rate, implant indication, heart rate, and AV event type were evaluated. Among 47 analysable patients, mean AV synchrony was achieved in 96.7% of beats, exceeding mean A-to-V and V-to-A transmission success rates of 93.4% and 92.1%, respectively. There were no significant differences in AV synchrony between sinus node and AV block patients. Across all AV paced/sensed cycle combinations and heart rate ranges (including >100 b.p.m.), AV synchrony was sustained >90% in an ambulatory real-world setting. Conclusion: A dual-chamber leadless pacing system demonstrated >96% overall AV synchrony for a 24 h period of daily living while programmed to clinically appropriate settings, thus showing that true dual-chamber DDD(R) pacing can be maintained in a real-world environment.Keywords
Funding Information
- Abbott Laboratories
This publication has 20 references indexed in Scilit:
- A Dual-Chamber Leadless PacemakerNew England Journal of Medicine, 2023
- Dual-chamber leadless pacing: Atrioventricular synchrony in preclinical models of normal or blocked atrioventricular conductionHeart Rhythm, 2023
- Leadless Cardiac Pacing: New HorizonsCardiology and Therapy, 2022
- Ambulatory atrioventricular synchronous pacing over time using a leadless ventricular pacemaker: Primary results from the AccelAV studyHeart Rhythm, 2022
- Leadless atrioventricular synchronous pacing in an outpatient setting: Early lessons learned on factors affecting atrioventricular synchronyHeart Rhythm, 2022
- Atrioventricular Synchronous Pacing Using a Leadless Ventricular PacemakerJACC: Clinical Electrophysiology, 2020
- 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive SummaryJACC, 2019
- Complications and Health Care Costs Associated With Transvenous Cardiac Pacemakers in a Nationwide AssessmentJACC: Clinical Electrophysiology, 2017
- A Leadless Intracardiac Transcatheter Pacing SystemNew England Journal of Medicine, 2016
- Incidence and predictors of short- and long-term complications in pacemaker therapy: The FOLLOWPACE studyHeart Rhythm, 2012